Related Experiment Video

Updated: Aug 10, 2026

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
11:34

Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity

Published on: January 10, 2013

Electrical stimulation in anterior limbs of internal capsules in patients with obsessive-compulsive disorder

B Nuttin, P Cosyns, H Demeulemeester

    Lancet (London, England)
    |November 7, 1999
    PubMed

    Abstract:

    Chronic electrical stimulation instead of bilateral capsulotomy was done in four selected patients with long-standing treatment-resistant obsessive-compulsive disorder. In three of them beneficial effects were observed.

    More Related Videos

    Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
    09:35

    Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

    Published on: May 10, 2017

    Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
    04:42

    Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

    Published on: June 26, 2018

    Related Experiment Videos

    Last Updated: Aug 10, 2026

    Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity
    11:34

    Breathing-controlled Electrical Stimulation (BreEStim) for Management of Neuropathic Pain and Spasticity

    Published on: January 10, 2013

    Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain
    09:35

    Subcutaneous Trigeminal Nerve Field Stimulation for Refractory Facial Pain

    Published on: May 10, 2017

    Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation
    04:42

    Treating Low Back Pain in Failed Back Surgery Patients with Multicolumn-lead Spinal Cord Stimulation

    Published on: June 26, 2018

    Related Concept Videos

    Electroconvulsive Therapy01:30

    Electroconvulsive Therapy

    Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early years,...

    Articles linked to this work by shared authors, journal, and citation graph.

    [Medical disciplinary law in Belgium].

    Tijdschrift voor psychiatrie·2024

    Deep brain stimulation for treatment-resistant major depressive disorder: a comparison of two targets and long-term follow-up.

    Translational psychiatry·2017

    Electrical stimulation of the bed nucleus of the stria terminalis reduces anxiety in a rat model.

    Translational psychiatry·2017

    Long-term electrical stimulation of bed nucleus of stria terminalis for obsessive-compulsive disorder.

    Molecular psychiatry·2016

    Electrical stimulation in the bed nucleus of the stria terminalis alleviates severe obsessive-compulsive disorder.

    Molecular psychiatry·2015

    [Sexual disorders in the DSM-5].

    Tijdschrift voor psychiatrie·2014

    Understanding peripheral arterial disease in the current era.

    Lancet (London, England)·2026

    Current advancements in the care of peripheral arterial disease: modern approaches to medical, endovascular, and surgical treatment.

    Lancet (London, England)·2026

    Peripheral arterial disease: adverse impacts, disparities in outcomes, and the path ahead.

    Lancet (London, England)·2026

    Developing roadmaps for advancing practice, research, and policy in the arts and health.

    Lancet (London, England)·2026

    Precision prevention and early detection: framework for a new clinical cancer control pathway.

    Lancet (London, England)·2026

    Switch to injectable cabotegravir-rilpivirine given every 8 weeks in adolescents living with HIV with virological suppression in sub-Saharan Africa (LATA): a randomised, open-label, multicentre, 96-week non-inferiority trial.

    Lancet (London, England)·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us